GE Healthcare invests $37.5m in Chinese bio-sciences facility

Published: 26-Sep-2005

UK headquartered medical devices and imaging technologies manufacturer, GE Healthcare is investing US$37.5m to extend its production facility in Shanghai.


UK headquartered medical devices and imaging technologies manufacturer, GE Healthcare is investing US$37.5m to extend its production facility in Shanghai.

The plant in Shanghai produces contrast media and medical technology products and is currently undergoing a review process to be the first US FDA-approved site for contrast media in China. Upon approval, the plant will be able to supply product beyond China to the US as well as numerous markets throughout the world.

Over the next five years, demand for contrast media in China alone is expected to see double-digit growth and so the company is making provisions for increased capacity.

Today, the Shanghai facility manufactures almost 5m units of X-Ray and magnetic resonance imaging (MRI) products. The expansion of the facility over the next two years will increase capacity to 15m units.

See more

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

Read more
The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years
Ingredients

GE Healthcare collaborates to develop ligands for AAV purification

Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies
Manufacturing

GE Healthcare Life Sciences launches software for cell therapy workflow

The SpinOculation C-Pro Protocol software closes and automates the cell transduction step
Research & Development

New Harvard consortium focuses on advanced bioproduction

The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Manufacturing

GE Healthcare launches new KUBio box for viral vector manufacturing

KUBio box is the latest addition to the KUBio modular bioprocessing portfolio
Ingredients

Research partnership removes bottleneck from AAV development

CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Design & Build

GE Healthcare and Germfree working on modular bioprocessing solution

The project is a rapidly deployable process-ready cleanroom and bioprocessing platforms for biotherapeutics such as gene therapy
Subscribe now